Enhanced mdr1 expression and chemoresistance of cancer stem cells derived from glioblastoma

Cancer Investigation

Volumn 27, Issue 9, 2009, Pages 901-908

  Nakai, Eiichi ^a   Park, Kaechang ^a   Yawata, Toshio ^a   Chihara, Takahiro ^a   Kumazawa, Ayano ^a   Nakabayashi, Hiromichi ^a   Shimizu, Keiji ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Cancer stem cell; Chemoresistance; Glioblastoma; MDR1

Indexed keywords

ABC TRANSPORTER; CARBOPLATIN; CARMUSTINE; CD133 ANTIGEN; DOXORUBICIN; ETOPOSIDE; MULTIDRUG RESISTANCE PROTEIN 1;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CANCER STEM CELL; CONTROLLED STUDY; DRUG SENSITIVITY; GLIOBLASTOMA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MOUSE; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

AGED; ANIMALS; ANTIGENS, CD; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; GLYCOPROTEINS; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASTIC STEM CELLS; P-GLYCOPROTEIN; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPHEROIDS, CELLULAR; UP-REGULATION;

EID: 70350150304     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357900801946679     Document Type: Article

References (25)

1. Salcman, M.; Scholtz, H.; Kaplan, R.S.; Kulik, S. Long-term survival in patients with malignant astrocytoma. Neurosurgery 1994, 34, 213-219.
2. Nieder, C.; Andratschke, N.; Wiedenmann, N.; Busch, R.; Grosu, A.L.; Molls, M. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome? Strahlenther Onkol 2004, 180, 401-407.
3. Shibui, S. Randomized controlled trial on malignant brain tumorsactivites of the Japan Clinical Oncology Group-Brain Tumor Study Group. Neuro Med. Chir. (Tokyo) 2004, 44, 220-221.
4. Singh, S.K.; Clarke, I.D.; Terasaki, M.; Bonn, V.E.; Hawkins, C.; Squire, J.; Dirks, P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63, 5821-5828.
5. Singh, S.K.; Hawkins, C.; Clarke, I.D.; Squire, J.A.; Bayani, J.; Hide, T.; Henkelman, R.M.; Cusimano, M.D.; Dirks, P.B. Identification of human brain tumour initiating cells. Nature. 2004, 432, 396-401.
6. Yuan, X.; Curtin, J.; Xiong, Y.; Liu, G.; Waschsmann-Hogiu, S.; Farkas, D.L.; Black, K.L.; Yu, J.S. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 2004, 23, 9392-9400.
7. Galli, R.; Binda, E.; Orfanelli, U.; Cipelletti, B.; Gritti, A.; De, Vitis S.; Fiocco, R.; Foroni, C.; Dimeco, F.; Vescovi, A. Isolation and characterization of tumorigenic, stem-like neural precursor from human glioblastoma. Cancer Res. 2004, 64, 7011-7021.
8. Dean, M.; Fojo, T.; Bates, S. Tumour stem cells and drug resistance. Nat. Rev. Cancer. 2005, 5, 275-284.
9. Zhou, S.; Schuetz, J.D.; Bunting, K.D.; Colapietro, A.M.; Sampath, J.; Morris, J.J.; Lagutina, I.; Grosveld, G.C.; Osawa, M.; Nakauchi, H.; Sorrentino, B.P. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 2001, 7, 1028-1034.
10. Hirschmann-Jax, C.; Foster, A.E.; Wulf, G.G.; Nuchtern, J.G.; Jax, TW.; Gobel, U.; Goodell, M.A.; Brenner, M.K. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc. Natl. Acad Sci. USA. 2004, 101, 14228-14233.
11. Schott, B.; Bennis, S.; Pourquier, P.; Ries, C.; Londos-Gagliardi, D.; Robert, J. Differential over-expression of mdr1 genes in multidrugresistant rat glioblastoma cell lines selected with doxorubicin or vincristine. Int. J. Cancer. 1993, 55, 115-121.
12. Kolchinsky, A.; Roninson, I.B. Drug resistance conferred by MDR1 expression in spheroids formed by glioblastoma cell lines. Anticancer Res. 1997, 17, 3321-3327.
13. Decleves, X.; Fajac, A.; Lehmann-Che, J.; Tardy, M.; Mercier, C.; Hurbain, I.; Laplanche, J.L.; Bernaudin, J.F.; Scherrmann, J.M. Molecular and functional MDR1-Pgp and MRPs expression in human glioblastoma multiforme cell lines. Int. J. Cancer. 2002, 98, 173-180.
14. Suzuki, T.; Maruno, M.; Wada, K.; Kagawa, N.; Fujimoto, Y.; Hashimoto, N.; Izumoto, S.; Yoshimine, T. Genetic analysis of human glioblastomas using a genomic microarray system. Brain Tumor Pathol. 2004, 21, 27-34.
15. Benyahia, B.; Huguet, S.; Decleves, X.; Mokhtari, K.; Crini ̀ere, E.; Bernaudin, J.F.; Scherrmann, J.M.; Delattre, J.Y. Multidrug resistance-associated protein MRP1 expression in human gliomas: chemosensitization to vincristine and etoposide by indomethacin in human glioma cell lines overexpressing MRP1. J. Neurooncol. 2004, 66, 65-70.
16. Romero-Isart, N.; Jensen, L.T.; Zerbe, O.; Winge, D.R.; Vasak, M. Engineering of metallothionein-3 neuroinhibitory activity into the inactive isoform metallothionein-1. J. Biol. Chem. 2002, 277, 37023-370238.
17. Hara, A.; Yamada, H.; Sakai, N.; Hirayama, H.; Tanaka, T.; Mori, H. Immunohistochemical demonstration of the placental form of glutathione S-transferase, a detoxifying enzyme in human gliomas. Cancer 1990, 66, 2563-2568.
18. Mousseau, M.; Chauvin, C.; Nissou, M.F.; Chaffanet, M.; Plantaz, D.; Pasquier, B.; Schaerer, R.; Benabid, A. Study of the expression of four chemoresistance-related genes in human primary and metastatic brain tumors. Eur. J. Cancer 1993, 29, 153-159.
19. Cai, S.; Xu, Y.; Cooper, R.J.; Hartwell, J.R.; Pollok, K.E.; Kelley, M.R. Mitochondrial targeting of human O6-methylguanine DNA methyltransferase protects against cell killing by chemotherapeutic alkylating agents. Cancer Res. 2005, 65, 3319-3327.
20. Liu, G.; Yuan, X.; Zeng, Z.; Tunici, P.; Tunici, P.; Ng, H.; Abdulkadir, I.R.; Lu, L.; Irvin, D.; Black, K.L.; Yu, J.S. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol. Cancer. 2006, 5, 67.
21. Singh, S.K.; Clarke, I.D.; Hide, T,; Dirks, P.B. Cancer stem cells in nervous system tumors. Oncogene 2004, 23, 7267-7273.
22. Kondo, T.; Setoguchi, T.; Taga, T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc. Natl. Acad Sci. USA. 2004, 101, 781-786.
23. Bao, S.;Wu, Q.; McLendon, R.E.; Hao, Y.; Hao, Y.; Shi, Q.; Hjelmeland, A.B.; Dewhirst, M.W.; Bigner, D.D.; Rich, J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006, 444, 756-760.
24. Chekhun, V.F.; Kulik, G.I.; Yurchenko, O.V.; Tryndyak, V.P.; Todor, I.N.; Luniv, L.S, Tregubova, N.A.; Pryzimirska, T.V.; Montgomery, B.; Rusetskaya, N.V.; Pogribny, I.P. Role of DNA hypomethylation in the development of the resistance to doxorubicin in human MCF-7 breast adenocarcinoma cells. Cancer Lett. 2006, 231, 87-93.
25. Tsang, W.P.; Kwoko, T.T. Riboregulator H19 induction of MDR1- associated drug resistance in human hepatocellular carcinoma cells. Oncogene. 2007, 26, 4877-4881.